clinical trialsosteoarthritismesenchymal stem cellsintra-articular injectioncartilage regenerationOsteoarthritis (OA) is a whole-joint disease primarily characterized by the deterioration of hyaline cartilage. Current treatments include microfracture and chondrocyte implantation as early surgical strategies...
定价:$ 111.87 装帧:HRD ISBN:9781852338749 豆瓣评分 目前无人评价 评价: 写笔记 写书评 加入购书单 分享到 推荐 内容简介· ··· Designed to be a practical handbook on clinical trial management in these key therapeutic areas, 'Clinical Trials in Rheumatoid Arthritis and Osteoarthritis' is aimed ...
Buchanan, WW, Kean, WF (2002) Osteoarthritis IV: clinical therapeutic trials and treatment. Inflammopharmacol 10: pp. 75-149Buchanan WW, Kean WF (2002c) Osteoarthritis IV: clinical therapeutic trials and treatment. Inflammopharmacol 10:75–149...
Mesenchymal stromal/stem cells (MSCs) are widely utilized in cell therapy because of their robust immunomodulatory and regenerative properties. Their paracrine activity is one of the most important features that contribute to their efficacy. Recently, it
An evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for Inter... pmhdev - 《Centre for Reviews & Dissemination》 被引量: 532发表: 2003年 Therapeutic trials in digital osteoarthritis. A critical review Although common, hand ...
A Task Force of the Osteoarthritis Research Society International (OARSI) has previously published a set of guidelines for the conduct of clinical trials in osteoarthritis (OA) of the hip and knee1. Limited material available on clinical trials of rehabilitation in people with OA has prompted OARSI...
Osteoarthritis (OA) is a degenerative multifactorial disease with concomitant structural, inflammatory, and metabolic changes that fluctuate in a temporal and patient-specific manner. This complexity has contributed to refractory responses to various treatments. MSCs have shown promise as multimodal therapeuti...
Purpose: Osteoarthritis (OA) of the knee is a debilitating, expensive, and prevalent disease, and interest in the non-surgical management of knee OA has grown recently. Our objective was to systematically assess the level of heterogeneity among all clinical trials and published studies regarding ...
Seven published clinical studies (Table 1) and 14 ongoing clinical trials (Table 2) (as of September 2022) tested MSC-Exos as a therapeutic agent against different diseases, including acute respiratory distress syndrome (ARDS), kidney diseases, graft-versus-host disease (GvHD), osteoarthritis, str...
Clinical trials in osteoarthritis. Author links open overlay panelL.M March, P.M BrooksShow more Add to Mendeley Share Cite https://doi.org/10.1136/ard.55.8.491Get rights and contentAccess through your organization Check access to the full text by signing in through your organization. Access...